Literature DB >> 26164664

Interferon Gamma Counteracts the Angiogenic Switch and Induces Vascular Permeability in Dextran Sulfate Sodium Colitis in Mice.

Lisa Haep1, Nathalie Britzen-Laurent, Thomas G Weber, Elisabeth Naschberger, Alexander Schaefer, Elisabeth Kremmer, Sebastian Foersch, Michael Vieth, Werner Scheuer, Stefan Wirtz, Maximilian Waldner, Michael Stürzl.   

Abstract

BACKGROUND: Interferon (IFN)-γ is a central pathogenesis factor in inflammatory bowel disease (IBD) with pleiotropic effects on many different cell types. However, as yet, the immune modulatory functions of IFN-γ in IBD have been predominantly investigated. Based on previous studies showing that IFN-γ acts antiangiogenic in colorectal carcinoma, we investigated the effects of IFN-γ on the vascular system in IBD.
METHODS: Colon tissues of patients with IBD and dextran sulfate sodium-induced colitis in mice were subjected to immunohistochemistry, quantitative real-time polymerase chain reactions, and in situ hybridization to quantify cell activation, angiogenesis, and immune responses. Vascular structure and permeability in mice were analyzed by ultramicroscopy and in vivo confocal laser endomicroscopy.
RESULTS: We showed a significantly increased blood vessel density in IBD and dextran sulfate sodium colitis. In mice, this was associated with a disorganized blood vessel structure and profound vascular leakage. As compared with genes associated with angiogenesis, genes associated with inflammatory cell activation including IFN-γ were more strongly upregulated in colitis tissues. IFN-γ exerted direct effects on endothelial cells in IBD tissues in vivo, as indicated by the expression of IFN-γ-induced guanylate binding protein 1 (GBP-1). Neutralization of IFN-γ in the acute dextran sulfate sodium colitis model demonstrated that this cytokine exerts endogenous angiostatic activity in IBD and contributes to increased vascular permeability.
CONCLUSIONS: The dissection of the pleiotropic activities of IFN-γ in IBD provides new insights to the pathological functions of this cytokine and may be of high relevance for the optimization of combination therapy approaches.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26164664     DOI: 10.1097/MIB.0000000000000490

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  17 in total

1.  IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.

Authors:  Victoria Langer; Eugenia Vivi; Daniela Regensburger; Thomas H Winkler; Maximilian J Waldner; Timo Rath; Benjamin Schmid; Lisa Skottke; Somin Lee; Noo Li Jeon; Thomas Wohlfahrt; Viktoria Kramer; Philipp Tripal; Michael Schumann; Stephan Kersting; Claudia Handtrack; Carol I Geppert; Karina Suchowski; Ralf H Adams; Christoph Becker; Andreas Ramming; Elisabeth Naschberger; Nathalie Britzen-Laurent; Michael Stürzl
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 2.  Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.

Authors:  Miles A Miller; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2016-06-04       Impact factor: 15.470

Review 3.  Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases.

Authors:  Nathalie Britzen-Laurent; Christian Herrmann; Elisabeth Naschberger; Roland S Croner; Michael Stürzl
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.

Authors:  Madelyn C Houser; Jianjun Chang; Stewart A Factor; Eric S Molho; Cyrus P Zabetian; Erin M Hill-Burns; Haydeh Payami; Vicki S Hertzberg; Malú G Tansey
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

5.  Chronic Toxoplasma gondii infection enhances susceptibility to colitis.

Authors:  Iti Saraav; Luisa Cervantes-Barragan; Philipp Olias; Yong Fu; Qiuling Wang; Leran Wang; Yi Wang; Matthias Mack; Megan T Baldridge; Thaddeus Stappenbeck; Marco Colonna; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

Review 6.  Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability.

Authors:  Lijun Du; John J Kim; Jinhua Shen; Ning Dai
Journal:  Gastroenterol Res Pract       Date:  2016-09-26       Impact factor: 2.260

Review 7.  Role of Inflammation in Pathophysiology of Colonic Disease: An Update.

Authors:  Noha Ahmed Nasef; Sunali Mehta
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

8.  Contrast-Enhanced µCT for Visualizing and Evaluating Murine Intestinal Inflammation.

Authors:  Dennis Jung; Rafael Heiss; Viktoria Kramer; Oana-Maria Thoma; Adrian P Regensburger; Wolfgang Rascher; Michael Uder; Markus F Neurath; Ferdinand Knieling; Maximilian J Waldner
Journal:  Theranostics       Date:  2018-12-07       Impact factor: 11.556

Review 9.  Interplay of GTPases and Cytoskeleton in Cellular Barrier Defects during Gut Inflammation.

Authors:  Rocío López-Posadas; Michael Stürzl; Imke Atreya; Markus F Neurath; Nathalie Britzen-Laurent
Journal:  Front Immunol       Date:  2017-10-05       Impact factor: 7.561

Review 10.  Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease.

Authors:  Eileen Haring; Robert Zeiser; Petya Apostolova
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.